Surface Oncology, Inc.

Home » Surface Oncology, Inc.

IPO

Surface Oncology, Inc.

We are a clinical-stage immuno-oncology company focused on using our specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment, or the TME, for the development of next-generation cancer therapies.

Symbol

SURF

Price Range
$15.00 - $15.00

Final Shares
7,200,000

Anticipated Date
TBD

Underwriters
Goldman Sachs, Cowen, Evercore ISI

To view the prospectus for Surface Oncology, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253